<DOC>
	<DOCNO>NCT02448199</DOCNO>
	<brief_summary>Phase III Study , double-blind , compare association anti-inflammatory anti-rheumatic 375 subject knee osteoarthritis .</brief_summary>
	<brief_title>Study Association Anti-inflammatory Anti-rheumatic</brief_title>
	<detailed_description>Evaluation 12 week treatment , 3 arm , efficacy safety association .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Meloxicam</mesh_term>
	<mesh_term>Anti-Inflammatory Agents</mesh_term>
	<mesh_term>Antirheumatic Agents</mesh_term>
	<criteria>Signs Informed Consent Form Age 40 85 year osteoarthritis knee accord clinical radiological criterion American College Rheumatology Cardiovascular disease Serious chronic comorbidity Hypersensitivity component study drug body mass index &gt; 30 kg / mÂ²</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>pain</keyword>
	<keyword>Knee</keyword>
</DOC>